STOCK TITAN

Thinking about buying stock in TOP Ships, Hertz, Biocept, Edesa Biotech, or Adamis Pharmaceuticals?

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

NEW YORK, June 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TOPS, HTZ, BIOC, EDSA, and ADMP.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

 

"Cision" View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-top-ships-hertz-biocept-edesa-biotech-or-adamis-pharmaceuticals-301076866.html

SOURCE InvestorsObserver

Edesa Biotech, Inc. Common Shares

NASDAQ:EDSA

EDSA Rankings

EDSA Latest News

EDSA Stock Data

14.65M
2.33M
18.69%
10.75%
0.61%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
MARKHAM

About EDSA

founded in 2015, edesa biotech brings innovative new treatments for dermatological and anorectal diseases. late-stage prescription drugs developed by edesa biotech aim to help patients who experience limited treatment options. edesa biotech's focus on dermatology is led by an experienced team that have licensed global rights to clinical stage assets for dermatology and anorectal indications.